Open AccessLung transplantation for post‐COVID ‐19 pulmonary fibrosis
Author(s) -
Gogia Pratibha,
Attawar Sandeep,
Singh Vivek,
Bhatnagar Tarun,
Sharma Sanjay,
Batra Khushboo,
Khare Swapnil
Publication year - 2021
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.862
Subject(s) - extracorporeal membrane oxygenation , medicine , pulmonary fibrosis , lung transplantation , mechanical ventilation , covid-19 , lung , weaning , respiratory failure , extracorporeal , transplantation , cardiology , intensive care medicine , disease , infectious disease (medical specialty)
COVID‐19 has affected over a billion people around the world, with over 2 million losing their lives (Worldometer). About 10% of patients infected with COVID‐19 develop a serious illness, including respiratory failure, that require advanced life‐supporting measures. Mortality among this subgroup exceeds 60%. We present a case of an otherwise healthy 34‐year‐old male who developed end‐stage pulmonary fibrosis following COVID‐19 infection. He achieved haemodynamic stability with mechanical ventilation and extracorporeal membrane oxygenation (ECMO) but did not show any sign of weaning off ECMO; however, he successfully underwent bilateral lung transplantation.